Search by Drug Name or NDC

NDC 65162-0926-50 Lacosamide 200 mg/1 Details

Lacosamide 200 mg/1

Lacosamide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is LACOSAMIDE.

MedlinePlus Drug Summary

Lacosamide is used to control partial onset seizures (seizures that involve only one part of the brain) in adults and children 1 month of age and older. Lacosamide is also used in combination with other medications to control primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 4 years of age and older. Lacosamide is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.

Related Packages: 65162-0926-50
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lacosamide

Product Information

NDC	65162-0926
Product ID	65162-926_4bc450e0-da81-432e-aef3-9e7c8fee8be0
Associated GPIs	72600036000350
GCN Sequence Number	064435
GCN Sequence Number Description	lacosamide TABLET 200 MG ORAL
HIC3	H4B
HIC3 Description	ANTICONVULSANTS
GCN	14342
HICL Sequence Number	035872
HICL Sequence Number Description	LACOSAMIDE
Brand/Generic	Generic
Proprietary Name	Lacosamide
Proprietary Name Suffix	n/a
Non-Proprietary Name	Lacosamide
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	200
Active Ingredient Units	mg/1
Substance Name	LACOSAMIDE
Labeler Name	Amneal Pharmaceuticals LLC
Pharmaceutical Class	Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA Schedule	CV
Marketing Category	ANDA
Application Number	ANDA204857
Listing Certified Through	2024-12-31

Package

NDC 65162-0926-50 (65162092650)

Pricing Information	N/A
NDC Package Code	65162-926-50
Billing NDC	65162092650
Package	500 TABLET in 1 BOTTLE (65162-926-50)
Marketing Start Date	2022-03-21
NDC Exclude Flag	N